-
公开(公告)号:US20250011791A1
公开(公告)日:2025-01-09
申请号:US18709305
申请日:2022-11-17
Inventor: Berge A. MINASSIAN , Emrah GUMUSGOZ , Mayank VERMA
IPC: C12N15/113 , A61P3/00 , A61P25/28 , C12N15/86
Abstract: The present disclosure provides methods and compositions for the treatment of glycogen storage disorders, such as, for example, Lafora Disease and adult polyglucosan body disease. The methods and compositions of the present disclosure comprise isolated nucleic acid molecules, rAAV vectors and rAAV viral vectors comprising polynucleotide sequences encoding for artificial micro RNAs (amiRNAs) directed against GYS1.